Cullinan Associates’s Dorman Products DORM Stock Holding History
Bought
Maintained
Sold
Other funds holding DORM
RA
GCM
GKIM
Cullinan Associates's DORM Position: Q1 2023 in Review
Cullinan Associates sold out of Dorman Products (DORM) in Q1 2023, closing a stake of 25,000 shares — an estimated $2.02M sold.
Cullinan Associates first reported a position in DORM in Q1 2021 and held it in 8 quarters. The position peaked at $2.83M in Q4 2021. 238 funds tracked by Wall St. Rank hold DORM as of Q1 2023.
- Cullinan Associates reported no remaining Dorman Products position as of Q1 2023 after selling out during the quarter.
- Cullinan Associates sold 25,000 Dorman Products shares in Q1 2023, an estimated $2.02M.
- Cullinan Associates first reported a position in Dorman Products in Q1 2021 and held it in 8 quarters.
- Cullinan Associates's Dorman Products position peaked at $2.83M in Q4 2021.
- 238 funds tracked by Wall St. Rank held Dorman Products as of Q1 2023.
Based on Cullinan Associates's 13F filing for Q1 2023, filed 5 Apr 2023.